• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Low miR-19b-1-5p expression in isolated platelets after aspirin use is related to aspirin insensitivity.

作者信息

Kok M G M, Mandolini C, Moerland P D, de Ronde M W J, Sondermeijer B M, Halliani A, Nieuwland R, Cipollone F, Creemers E E, Meijers J C M, Pinto-Sietsma S J

机构信息

Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands; Department of Experimental Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

Department of Experimental Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands; Department of Hypertension and Dyslipidemia, Geriatric Clinic and European Center on Atherosclerosis, G. D'Annunzio University, Chieti, Italy.

出版信息

Int J Cardiol. 2016 Jan 15;203:262-3. doi: 10.1016/j.ijcard.2015.10.098. Epub 2015 Oct 23.

DOI:10.1016/j.ijcard.2015.10.098
PMID:26519680
Abstract
摘要

相似文献

1
Low miR-19b-1-5p expression in isolated platelets after aspirin use is related to aspirin insensitivity.阿司匹林使用后分离的血小板中低水平的miR-19b-1-5p表达与阿司匹林不敏感有关。
Int J Cardiol. 2016 Jan 15;203:262-3. doi: 10.1016/j.ijcard.2015.10.098. Epub 2015 Oct 23.
2
Low miR-19b-1-5p Expression Is Related to Aspirin Resistance and Major Adverse Cardio- Cerebrovascular Events in Patients With Acute Coronary Syndrome.低 miR-19b-1-5p 表达与急性冠状动脉综合征患者的阿司匹林抵抗和主要不良心脑血管事件相关。
J Am Heart Assoc. 2021 Jan 19;10(2):e017120. doi: 10.1161/JAHA.120.017120. Epub 2021 Jan 14.
3
Association of plasma miR-223 and platelet reactivity in patients with coronary artery disease on dual antiplatelet therapy: A preliminary report.双重抗血小板治疗的冠心病患者血浆miR-223与血小板反应性的关联：初步报告
Platelets. 2015;26(6):593-7. doi: 10.3109/09537104.2014.974527. Epub 2014 Oct 28.
4
Why an aspirin a day no longer keeps the doctor away ….为何每天服用一片阿司匹林不再能让你远离医生……
Thromb Haemost. 2011 Feb;105(2):209-10. doi: 10.1160/TH10-11-0749. Epub 2010 Dec 6.
5
24-hour time-dependent aspirin efficacy in patients with stable coronary artery disease.稳定性冠心病患者的 24 小时时间依赖性阿司匹林疗效。
Thromb Haemost. 2011 Feb;105(2):336-44. doi: 10.1160/TH10-02-0082. Epub 2010 Dec 7.
6
Platelet miRNA-26b down-regulates multidrug resistance protein 4 in patients on chronic aspirin treatment.慢性阿司匹林治疗患者血小板 miRNA-26b 下调多药耐药蛋白 4。
J Cardiovasc Med (Hagerstown). 2018 Oct;19(10):611-613. doi: 10.2459/JCM.0000000000000691.
7
Antitumor effect of antiplatelet agents in gastric cancer cells: an in vivo and in vitro study.抗血小板药物对胃癌细胞的抗肿瘤作用：一项体内和体外研究。
Gastric Cancer. 2016 Jul;19(3):817-26. doi: 10.1007/s10120-015-0556-2. Epub 2015 Oct 20.
8
Evaluation of aspirin response by Multiplate whole blood aggregometry and light transmission aggregometry.采用 Multiplate 全血聚集仪和透光比浊法评估阿司匹林反应。
Platelets. 2009 Sep;20(6):415-20. doi: 10.1080/09537100903100643.
9
Homocysteine is a novel risk factor for suboptimal response of blood platelets to acetylsalicylic acid in coronary artery disease: a randomized multicenter study.同型半胱氨酸是冠心病患者血小板对乙酰水杨酸反应不佳的新的危险因素：一项随机多中心研究。
Pharmacol Res. 2013 Aug;74:7-22. doi: 10.1016/j.phrs.2013.04.010. Epub 2013 May 7.
10
Polymorphisms associated with in vitro aspirin resistance are not associated with clinical outcomes in patients with coronary artery disease who report regular aspirin use.与体外阿司匹林抵抗相关的多态性与报告常规使用阿司匹林的冠心病患者的临床结局无关。
Am Heart J. 2011 Jul;162(1):166-72.e1. doi: 10.1016/j.ahj.2011.03.026.

引用本文的文献

1
Evaluation of response to clopidogrel in patients with CYP2C19*2/*3 polymorphisms and its association with miR-19b expression.CYP2C19*2/*3基因多态性患者对氯吡格雷的反应评估及其与miR-19b表达的关联。
Mol Biol Rep. 2025 Apr 9;52(1):374. doi: 10.1007/s11033-025-10482-7.
2
The pharmaco-epigenetics of hypertension: a focus on microRNA.高血压的药物-表观遗传学：以 microRNA 为重点。
Mol Cell Biochem. 2024 Dec;479(12):3255-3271. doi: 10.1007/s11010-024-04947-9. Epub 2024 Feb 29.
3
Cardiovascular complications of diabetes: role of non-coding RNAs in the crosstalk between immune and cardiovascular systems.
糖尿病的心血管并发症：非编码 RNA 在免疫和心血管系统相互作用中的作用。
Cardiovasc Diabetol. 2023 May 24;22(1):122. doi: 10.1186/s12933-023-01842-3.
4
The Novel Role of Noncoding RNAs in Modulating Platelet Function: Implications in Activation and Aggregation.非编码 RNA 在调节血小板功能中的新作用：在激活和聚集中的意义。
Int J Mol Sci. 2023 Apr 21;24(8):7650. doi: 10.3390/ijms24087650.
5
DNA methylation profile in the whole blood of acute coronary syndrome patients with aspirin resistance.阿司匹林抵抗的急性冠脉综合征患者全血中的 DNA 甲基化谱。
J Clin Lab Anal. 2023 Jan;37(1):e24821. doi: 10.1002/jcla.24821. Epub 2022 Dec 22.
6
MicroRNAs in Kawasaki disease: An update on diagnosis, therapy and monitoring.川崎病相关 microRNAs：诊断、治疗和监测的新进展。
Front Immunol. 2022 Oct 24;13:1016575. doi: 10.3389/fimmu.2022.1016575. eCollection 2022.
7
Insights Into Platelet-Derived MicroRNAs in Cardiovascular and Oncologic Diseases: Potential Predictor and Therapeutic Target.心血管疾病和肿瘤疾病中血小板衍生微小RNA的见解：潜在的预测指标和治疗靶点
Front Cardiovasc Med. 2022 Jun 9;9:879351. doi: 10.3389/fcvm.2022.879351. eCollection 2022.
8
Circulating and Platelet MicroRNAs in Cardiovascular Risk Assessment and Antiplatelet Therapy Monitoring.循环及血小板中的微小RNA在心血管风险评估和抗血小板治疗监测中的作用
J Clin Med. 2022 Mar 22;11(7):1763. doi: 10.3390/jcm11071763.
9
AMD Genomics: Non-Coding RNAs as Biomarkers and Therapeutic Targets.年龄相关性黄斑变性基因组学：非编码RNA作为生物标志物和治疗靶点
J Clin Med. 2022 Mar 9;11(6):1484. doi: 10.3390/jcm11061484.
10
Identification of the TF-miRNA-mRNA co-regulatory networks involved in sepsis.鉴定脓毒症中涉及的 TF-miRNA-mRNA 共调控网络。
Funct Integr Genomics. 2022 Aug;22(4):481-489. doi: 10.1007/s10142-022-00843-x. Epub 2022 Mar 24.